Lodonal™ Expected to Receive International Exposure at the World Health Assembly, one of the World’s Leading Health Forums
May 18, 2016 14:05 ET
|
Immune Therapeutics, Inc.
ORLANDO, Fla., May 18, 2016 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a clinical-stage biotech company providing immunotherapy solutions for the treatment of infectious and...
Immune Therapeutics Receives NAFDAC Approval for Lodonal(TM) in Nigeria: Approval Follows Successful Recent Bridging Study
April 27, 2016 10:19 ET
|
Immune Therapeutics, Inc.
ORLANDO, Fla., April 27, 2016 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN) (the “Company”), a clinical-stage biotech company providing immunotherapy solutions for the treatment...